Pfizer's Oral COVID-19 Drug Paxlovid Deployed in Shanghai Community Health Centers

Pfizer's COVID-19 Oral Drug Paxlovid (Nirmatrelvir Tablets/Ritonavir Tablets Combination) Has Been Put Into Use at Some Community Health Service Centers in Shanghai and Can Be Covered by Medical Insurance. For Example, it Has Already Been Used Clinically at the Yu Garden Subdistrict Community Health Service Center in Huangpu District. Chen Jianxin, Deputy Director of the Malu Town Community Health Service Center in Jiading District, Revealed That Their Service Center Also Has Pfizer’s COVID-19 Oral Drug in Reserve, Which is Currently Only Provided to Patients Aged 65 and Above Who May Develop Severe Illness, and Is Not Yet Available to General Patients. (The Paper)